Eye Care News

Fast-spiking neurons in the basal ganglia allow monkeys to associate different values with the same objects based on the surrounding environment. Blocking input from these cells inhibited learning of new scene-based values, but did not erase already learned associations. This could help understand clinical conditions such as Tourette syndrome, which is characterized by reduced input from these cells.

Simple vision tests can predict which people with Parkinson’s disease will develop cognitive impairment and possible dementia 18 months later, according to a new study. In a related study, the researchers also found that structural and functional connections of brain regions become decoupled throughout the entire brain in people with Parkinson’s disease, particularly among people with vision problems.

Scientists studying the body’s natural defenses against bacterial infection have identified a nutrient — taurine — that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding could aid efforts seeking alternatives to antibiotics.

An innovative new study is set to examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

In experiments in mouse tissues and human cells, researchers say they have found that removing a membrane that lines the back of the eye may improve the success rate for regrowing nerve cells damaged by blinding diseases.

This week, a travoprost intracameral implant shows encouraging phase 1 results, the ILM could play a key role in repairing damaged retinas and acupuncture treatment leaves a patient seeing lights.

This 28-year retrospective chart review reports the outcomes of goniosurgery for children with glaucoma associated with Sturge-Weber syndrome.

This week, Glaukos reports positive results from 2 glaucoma trials, CorNeat Vision’s artificial cornea is implanted into its first trial participant and Notal Vision tests out their at-home OCT platform for monitoring AMD.

This multicenter, prospective case series evaluated changes in ongoing immunomodulatory and biologic therapies used for noninfectious uveitis during the COVID-19 pandemic.

This retrospective, interventional case series evaluated the long-term safety and efficacy of accelerated transepithelial CXL in pediatric eyes with progressive keratoconus.